Next, the impact of SELENBP1 deletion on the immunological function of DCs was investigated in vitro, and the efficacy of SELENBP1-deficient DC transfusion in sepsis-infected mice was evaluated. This evidence concerns the gene SELENBP1 and Sepsis.